Tag: canakinumab
Canakinumab not associated with increased survival without invasive mechanical ventilation among patients hospitalized with severe COVID-19
1. Among patients hospitalized with severe COVID-19 and hyperinflammation, treatment using the anti-interleukin-1β antibody canakinumab, compared with placebo, did not ...
Inhibition of inflammation through interleukin pathway may be protective against anemia
1. In this secondary analysis of data from the CANTOS trial in 2017, canakinumab significantly reduced the incidence of anemia ...
Quarterly canakinumab administration associated with significantly reduced risk for gout attacks
1. Use of canakinumab was associated with reduced risk for gout attacks. 2. Canakinumab administration did not result in changes ...